ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.850,18
0,38%
S&P 500
6.115,07
1,04%
US Dollar vs BRL
5,767
-0,02%
Bitcoin
96.643,80
0,03%
Brent Oil
75,09
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Rapport Therapeutics Inc (RAPP)

  7. Rapport Therapeutics Inc (RAPP) Notícias

RAPP

Rapport Therapeutics (RAPP)

Rapport Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RAPP
DataHoraFonteTítuloCódigoCompanhia
04/02/202519:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
10/01/202508:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
09/01/202511:12GlobeNewswire Inc.CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersNASDAQ:RAPPRapport Therapeutics Inc
09/01/202509:00GlobeNewswire Inc.Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersNASDAQ:RAPPRapport Therapeutics Inc
06/12/202414:01GlobeNewswire Inc.Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical SeizuresNASDAQ:RAPPRapport Therapeutics Inc
14/11/202409:00GlobeNewswire Inc.Rapport Therapeutics to Present Data at American Epilepsy Society Annual MeetingNASDAQ:RAPPRapport Therapeutics Inc
07/11/202420:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
07/11/202409:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAPPRapport Therapeutics Inc
07/11/202409:00GlobeNewswire Inc.Rapport Therapeutics Reports Third Quarter Financials and Provides Business UpdateNASDAQ:RAPPRapport Therapeutics Inc
04/11/202409:00GlobeNewswire Inc.Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in NovemberNASDAQ:RAPPRapport Therapeutics Inc
05/09/202408:00GlobeNewswire Inc.Rapport Therapeutics to Present at Upcoming Epilepsy Medical ConferencesNASDAQ:RAPPRapport Therapeutics Inc
29/08/202408:00GlobeNewswire Inc.Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry SummitNASDAQ:RAPPRapport Therapeutics Inc
08/08/202408:00GlobeNewswire Inc.Rapport Therapeutics Reports Second Quarter Financials and Provides Business UpdateNASDAQ:RAPPRapport Therapeutics Inc
29/07/202408:00GlobeNewswire Inc.Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on PainNASDAQ:RAPPRapport Therapeutics Inc
12/06/202417:01GlobeNewswire Inc.Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private PlacementNASDAQ:RAPPRapport Therapeutics Inc
06/06/202419:54GlobeNewswire Inc.Rapport Therapeutics Announces Pricing of Initial Public OfferingNASDAQ:RAPPRapport Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RAPP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios